Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function-an exploratory analysis.

"Declarations Conflict of interestThe authors declare the following financial interest/personal relationships which may be considered as potential competing interests: dr. A.M.E. Walenkamp: Grant: Dutch Cancer Society (inst). Research funding: Abbvie (inst), BMS (inst), Genzyme (inst), Karyopharm Therapeutics (inst), Roche (inst). Consulting of advisory role: Polyphor (inst), IPSEN (inst), Karyopharm (inst), Novartis (inst). Prof. Dr. J.A. Gietema: Research funding: Abbvie (inst), Roche (inst), Siemens (inst). No other potential conflicts of interest are reported by any of the authors. Consent to participateWritten informed consent was obtained from all patients. Conflict of interest The authors declare the following financial interest/personal relationships which may be considered as potential competing interests: dr. A.M.E. Walenkamp: Grant: Dutch Cancer Society (inst). Research funding: Abbvie (inst), BMS (inst), Genzyme (inst), Karyopharm Therapeutics (inst), Roche (inst). Consulting of advisory role: Polyphor (inst), IPSEN (inst), Karyopharm (inst), Novartis (inst). Prof. Dr. J.A. Gietema: Research funding: Abbvie (inst), Roche (inst), Siemens (inst). No other potential conflicts of interest are reported by any of the authors."

"Funding This work was supported by the Dutch Cancer Society, Alpe d’HuZes (Grant number: DCS 2011–5265) and the Graduate School of Medical Sciences, University of Groningen. The study's funders had no role in the design, data collection, management, analysis, interpretation, report writing and decision to submit the manuscript."

"Trial registry: Optimal Timing of Physical Activity in Cancer Treatment (ACT) Registry URL: https://clinicaltrials.gov/ct2/show/NCT01642680. Trial registration number: NCT01642680."